Skip to main content

REVIEW article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1343316

A Review of Natural Products Targeting Tumor Immune Microenvironments for the Treatment of Lung Cancer

 Pengyu Yao1  Su Liang1* Zhenying Liu2 Cuiping Xu3*
  • 1Jinan Maternity And Child Care Hospital affiliated to Shandong first Medical University, China
  • 2China Academy of Chinese Medical Sciences, China
  • 3The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, China

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Lung cancer(LC) produces some of the most malignant tumors in the world, with high morbidity and mortality. Tumor immune microenvironment (TIME), a component of the tumor microenvironment (TME), are critical in tumor development, immune escape, and drug resistance. The TIME is composed of various immune cells, immune cytokines, etc, which are important biological characteristics and determinants of tumor progression and outcomes. In this paper, we reviewed the recently published literature and discussed the potential uses of natural products in regulating TIME.We observed that a total of 37 natural compounds have been reported to exert anti-cancer effects by targeting the TIME. In different classes of natural products, terpenoids are the most frequently mentioned compounds. TAMs are one of the most investigated immune cells about therapies with natural products in TIME, with 9 natural products acting through it. 17 natural products exhibit anticancer properties in LC by modulating PD-1 and PD-L1 protein activity. These natural products have been extensively evaluated in animal and cellular LC models, but their clinical trials in LC patients are lacking. Based on the current review, we have revealed that the mechanisms of LC can be treated with natural products through TIME intervention, resulting in a new perspective and potential therapeutic drugs.

Keywords: natural compounds, lung cancer, tumor immune microenvironments, immune cells, Immune cytokines, review

Received: 23 Nov 2023; Accepted: 18 Jan 2024.

Copyright: © 2024 Yao, Liang, Liu and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Ms. Su Liang, Jinan Maternity And Child Care Hospital affiliated to Shandong first Medical University, Jinan, China
Dr. Cuiping Xu, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, 250014, Shandong Province, China